ACTIVE

CREATIF 9 INVEST

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result64,9 k €-73,2 %over 1 year
Gross margin147,8 k €-69,7 %over 1 year
Equity243,8 k €+36,2 %over 1 year

Identity

Source · BCE/KBO

CREATIF 9 INVEST is a Public limited company incorporated in 1989. Its main activity is: Rental and operating of own or leased real estate. Its registered office is in Ottignies-Louvain-la-Neuve.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0437.042.705
Incorporation
27/02/1989
Legal form
Public limited company
Registered office
Avenue des Combattants 91
1340 Ottignies-Louvain-la-Neuve · WallonieSee on map
Contributed capital
80 000,00 €
Latest accounts
30/06/2025
Joint committees (2)
  • 100
  • 218
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin147,8 k €487,6 k €274,5 k €232,7 k €131,3 k €
EBITDA124,9 k €443,3 k €205 k €182,1 k €110,5 k €
Operating result66,3 k €384,7 k €115,3 k €96 k €24,5 k €
Net result64,9 k €242,2 k €69,8 k €36,2 k €-13,1 k €
Balance sheet
Equity243,8 k €178,9 k €-63,3 k €-133,1 k €-169,3 k €
Total assets897,5 k €978,7 k €1,4 M €1,6 M €1,6 M €
Cash49,2 k €146,6 k €18,2 k €55 k €7,5 k €
Debts470,5 k €611,5 k €1,4 M €1,7 M €1,7 M €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 14 ended

Active mandates

Jehan Lienart van Lindth de Jeude

Managing director

Active
Nathalie Geruzet

Managing director

Active
VESALE PHARMACEUTICA

Director · 0452.282.591

Represented by Jehan Lienart van Linth de Jeude

Active

Ended mandates

Business et Epicure

Director · since 29 octobre 2010 · until 18 mai 2016 · 0830.476.188

Represented by Jean-Louis Six

Ended
Pharmadis

Managing director · since 29 octobre 2010 · until 18 mai 2016

Represented by Jean-Pol Warzée

Ended
VESALE PHARMACEUTICA

Director · since 29 octobre 2010 · until 18 mai 2016 · 0452.282.591

Represented by Johan Quintens

Ended
Jehan Lienart van Lidth de Jeude

Managing director · since 22 avril 2004 · until 18 mai 2010

Ended

Other companies at this address

Avenue des Combattants 91 1340 Ottignies-Louvain-la-Neuve
CompanyCBE no.
Business et Epicure● Active
0830.476.188
GEMADIS● Active
0444.435.291
MYELIN● Active
0533.961.838

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date27/02/202625/02/202504/03/202401/02/202327/09/202221/01/2021
General meeting01/12/202502/12/202404/12/202305/12/202206/12/202107/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202501/12/202527/02/2026FrenchPDF
Micro model30/06/202402/12/202425/02/2025FrenchPDF
Micro model30/06/202304/12/202304/03/2024FrenchPDF
Micro model30/06/202205/12/202201/02/2023FrenchPDF
Micro model30/06/202106/12/202127/09/2022FrenchPDF
Micro model30/06/202007/12/202021/01/2021FrenchPDF
Micro model30/06/201902/12/201913/03/2020FrenchPDF
Micro model31/12/201722/05/201813/12/2018FrenchPDF
Abridged model31/12/201615/05/201704/10/2017FrenchPDF
Abridged model31/12/201517/05/201630/09/2016FrenchPDF
Abridged model31/12/201418/05/201531/08/2015FrenchPDF
Abridged model31/12/201319/05/201420/10/2014FrenchPDF
Abridged model31/12/201221/05/201330/09/2013FrenchPDF
Abridged model31/12/201121/05/201229/08/2012FrenchPDF
Abridged model31/12/201017/05/201131/08/2011FrenchPDF
Abridged model31/12/200917/05/201031/08/2010FrenchPDF
Abridged model31/12/200819/05/200918/11/2009FrenchPDF
Abridged model31/12/200719/05/200829/08/2008FrenchPDF
Abridged model31/12/200605/06/200731/08/2007FrenchPDF
Abridged model31/12/200508/12/200614/05/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 14 ended

Active mandates

Jehan Lienart van Lindth de Jeude

Managing director

Active
Nathalie Geruzet

Managing director

Active
VESALE PHARMACEUTICA

Director · 0452.282.591

Represented by Jehan Lienart van Linth de Jeude

Active

Ended mandates

Business et Epicure

Director · since 29 octobre 2010 · until 18 mai 2016 · 0830.476.188

Represented by Jean-Louis Six

Ended
Pharmadis

Managing director · since 29 octobre 2010 · until 18 mai 2016

Represented by Jean-Pol Warzée

Ended
VESALE PHARMACEUTICA

Director · since 29 octobre 2010 · until 18 mai 2016 · 0452.282.591

Represented by Johan Quintens

Ended
Jehan Lienart van Lidth de Jeude

Managing director · since 22 avril 2004 · until 18 mai 2010

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates13/11/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office08/02/2019
    SIEGE SOCIAL
    PDF
  • Other11/12/2018
    ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Mandates04/09/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/05/2014
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates26/07/2012
    DEMISSIONS, NOMINATIONS - DIVERS
    PDF
  • Registered office12/04/2012
    SIEGE SOCIAL
    PDF
  • Mandates08/04/2010
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202564,9 k €↓
  2. 2024
    Annual accounts 2024242,2 k €↑
  3. 2023
    Annual accounts 202369,8 k €↑
  4. 2022
    Annual accounts 202236,2 k €↑
  5. 2021
    Annual accounts 2021-13,1 k €↓
  6. 2020
    Annual accounts 20201,6 k €↓
  7. 2019
    Annual accounts 201939,2 k €↓
  8. 2017
    Annual accounts 201756,7 k €↑
  9. 2016
    Annual accounts 2016-66,3 k €↓
  10. 2015
    Annual accounts 2015100 k €↑
  11. 2014
    Annual accounts 2014-87,1 k €↓
  12. 2013
    Annual accounts 2013-26,3 k €↓
  13. 2012
    Annual accounts 2012-25,9 k €↑
  14. 2011
    Annual accounts 2011-124,8 k €↓
  15. 2010
    Annual accounts 20103 k €↑
  16. 2009
    Annual accounts 2009-265,3 k €↓
  17. 2008
    Annual accounts 2008-11,5 k €↓
  18. 2007
    Annual accounts 20071,4 k €
  19. 27/02/1989
    IncorporationPublic limited company